RNU6-970P

Across TCGA pan-cancer cohorts, RNU6-970P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-970P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-970P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-970P expression acts as an unfavorable survival marker.

KIRC, BLCA, and THYM are the cancer types where RNU6-970P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
BLCA	DFS	Tertile	III,IV	0.122	0.572	.004	36	view →
THYM	DFS	Tertile	II,III,IV	0.243	0.772	.006	21	view →
UCEC	DFS	Tertile	All	0.163	0.652	.033	12	view →
SKCM	DFS	Tertile	All	0.023	0.729	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-970P–KIRC (DFS)

Open the KIRC breakdown →